Correlation Between MediciNova and Covalon Technologies
Can any of the company-specific risk be diversified away by investing in both MediciNova and Covalon Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Covalon Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Covalon Technologies, you can compare the effects of market volatilities on MediciNova and Covalon Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Covalon Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Covalon Technologies.
Diversification Opportunities for MediciNova and Covalon Technologies
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between MediciNova and Covalon is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Covalon Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Covalon Technologies and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Covalon Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Covalon Technologies has no effect on the direction of MediciNova i.e., MediciNova and Covalon Technologies go up and down completely randomly.
Pair Corralation between MediciNova and Covalon Technologies
Given the investment horizon of 90 days MediciNova is expected to under-perform the Covalon Technologies. But the stock apears to be less risky and, when comparing its historical volatility, MediciNova is 1.27 times less risky than Covalon Technologies. The stock trades about -0.2 of its potential returns per unit of risk. The Covalon Technologies is currently generating about -0.15 of returns per unit of risk over similar time horizon. If you would invest 266.00 in Covalon Technologies on December 2, 2024 and sell it today you would lose (82.00) from holding Covalon Technologies or give up 30.83% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
MediciNova vs. Covalon Technologies
Performance |
Timeline |
MediciNova |
Covalon Technologies |
MediciNova and Covalon Technologies Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MediciNova and Covalon Technologies
The main advantage of trading using opposite MediciNova and Covalon Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Covalon Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Covalon Technologies will offset losses from the drop in Covalon Technologies' long position.MediciNova vs. Aerovate Therapeutics | MediciNova vs. Adagene | MediciNova vs. Acrivon Therapeutics, Common | MediciNova vs. Rezolute |
Covalon Technologies vs. Biotron Limited | Covalon Technologies vs. biOasis Technologies | Covalon Technologies vs. Mosaic Immunoengineering | Covalon Technologies vs. Cellectis SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |